tiprankstipranks
Trending News
More News >
Crispr Therapeutics (CRSP)
NASDAQ:CRSP
US Market

Crispr Therapeutics AG (CRSP) Income Statement

Compare
10,703 Followers

Crispr Therapeutics AG Income Statement

Last quarter (Q3 2025), Crispr Therapeutics AG's total revenue was $889.00K, an increase of Infinity% from the same quarter last year. In Q3, Crispr Therapeutics AG's net income was $-106.44M. See Crispr Therapeutics AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 35.00M$ 370.00M$ 436.00K$ 913.08M$ 719.00K
Gross Profit
$ -75.25M$ 239.75M$ -109.81M$ 811.90M$ -268.69M
Operating Expenses
$ 391.32M$ 462.29M$ 563.35M$ 438.38M$ 85.75M
Depreciation and Amortization
$ 19.26M$ 19.84M$ 24.17M$ 17.95M$ 9.18M
EBITDA
$ -447.31M$ -202.70M$ -648.99M$ 391.48M$ -345.25M
Operating Income
$ -466.57M$ -222.54M$ -673.16M$ 373.53M$ -354.44M
Other Income/Expenses
$ 103.90M$ 71.82M$ 22.66M$ 6.00M$ 6.38M
Pretax Income
$ -362.67M$ -150.72M$ -650.50M$ 379.53M$ -348.06M
Net Income
$ -366.25M$ -153.61M$ -650.17M$ 377.66M$ -348.87M
Per Share Metrics
Basic EPS
$ -4.34$ -1.94$ -8.36$ 4.97$ -5.29
Diluted EPS
$ -4.34$ -1.94$ -8.36$ 4.70$ -5.29
Weighted Average Shares Outstanding
84.36M 79.22M 77.75M 75.95M 65.95M
Weighted Average Shares Outstanding (Diluted)
84.36M 79.22M 77.75M 80.39M 65.95M
Currency in USD

Crispr Therapeutics AG Earnings and Revenue History